Evidence map›Paper›PMID 40047589›Full record

ArticleMicromachines2025

A New Means to Generate Liposomes by Rehydrating Engineered Lipid Nanoconstructs.

Yuqi Huang, Ziqian Xu, Umit Celik, Christopher F Carnahan, Roland Faller, Atul N Parikh, Gang-Yu Liu

Abstract read
In one paragraph

Article in Micromachines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuqi HuangDepartment of Chemistry, University of California, Davis, CA 95616, USA.ORCID 0000-0001-5993-9862
Ziqian XuDepartment of Chemistry, University of California, Davis, CA 95616, USA.ORCID 0009-0000-3051-2697
Umit CelikDepartment of Chemistry, University of California, Davis, CA 95616, USA.ORCID 0000-0002-7759-6821
Christopher F CarnahanBiophysics Graduate Group, University of California, Davis, CA 95616, USA.
Roland FallerDepartment of Chemical Engineering, University of California, Davis, CA 95616, USA.ORCID 0000-0001-9946-3846
Atul N ParikhBiophysics Graduate Group, University of California, Davis, CA 95616, USA.ORCID 0000-0002-5927-4968
Gang-Yu LiuDepartment of Chemistry, University of California, Davis, CA 95616, USA.ORCID 0000-0003-3689-0685

Funding

National Science Foundation CHE-2304986TÜBİTAK 2219/1059B191700279
6 · The paper itself

Abstract

The concept and feasibility of producing liposomes by rehydrating engineered lipid nanoconstructs are demonstrated in this study. Nanoconstructs of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) were produced using a microfluidic delivery probe integrated with an atomic force microscope. The subsequent rehydration of these POPC constructs led to the formation of liposomes, most of which remained adhered to the surface. The size (e.g., diameter) of the liposomes could be tuned by varying the lateral dimension of the lipid constructs. Hierarchical liposomal structures, such as pentagons containing five liposomes at the corners, could also be designed and produced by depositing lipid constructs to designated locations on the surfaces, followed by rehydration. This new means allows for regulating liposomal sizes, distributions, and compositions. The outcomes benefit applications of liposomes as delivery vehicles, sensors, and building blocks in biomaterials design. The ability to produce hierarchical liposomal structures benefits numerous applications such as proto-cell development, multiplexed bio-composite materials, and the engineering of local bio-environments.

Indexed as

1-palmitoyl-2-oleoyl-sn-glycero3-phosphocholine (POPC)3D nanoprintingatomic force microscopy (AFM)lipidliposomemicrofluidic

Identifiers

PMID40047589
PMCPMC11857817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.